Mid-term results for second-generation thoracic stent grafts

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Medical Device Technology

Background:

• Thoracic stent grafts present an alternative to traditional open surgery for treating thoracic aortic disease.
• Long-term durability data for commercially available thoracic stent graft devices remain largely unknown.
• This study provides mid-term follow-up results for patients treated with thoracic stent grafts.

Purpose of the Study:

• To evaluate the mid-term safety and efficacy of endoluminal stent grafts for thoracic aortic pathology.
• To assess the complication rates and outcomes associated with thoracic stent graft repair.
• To compare the results of endoluminal repair with open surgical repair for thoracic aortic disease.

Main Methods:

• Prospective data collection on patients undergoing endoluminal graft procedures for thoracic aortic pathology.
• Analysis of patient demographics, procedural details, and short-term outcomes (30-day mortality, stroke, paraplegia).
• Mid-term follow-up assessment including mortality, device-related complications, and need for reintervention.

Main Results:

• A total of 67 patients received thoracic stent grafts between July 1997 and October 2002.
• 30-day mortality rates were 2% for elective and 16% for urgent repairs.
• Mid-term follow-up (median 17 months) revealed complications including endoleaks and aneurysm rupture; 4% experienced paraplegia, and 4% had a stroke.

Conclusions:

• Endoluminal repair of thoracic aortic pathology demonstrates mid-term safety as an alternative to open surgery.
• Continued patient surveillance is essential to monitor for late complications and ensure long-term device performance.
• Thoracic stent grafts offer a viable option, but careful patient selection and follow-up are critical.